Date: January 9-11, 2008
Venue: CIPT Auditorium, Calcutta Institute of Pharmaceutical Technology Uluberia, Howrah
Summary: The theme of the conference is ‘Safer Medicines—Better Medicines’. Medicines are intended to relieve human suffering. Therefore patients and doctors find it offensive that they cause disease. Adverse drug reaction (ADR) reporting and monitoring system is important for collecting, collating and analysing data as a means of establishing new knowledge and generating early signals of possible drug complications. Pharmacovigilance refers to all such activities. The conference will be attended by selected expert clinicians, pharmacologists, clinical pharmacists, industry representatives and other stakeholders of pharmacovigilance from around the world.
IDMA’s 47th Annual Celebration
Date: January 16, 2009
Venue: Hotel Hyatt Regency, Sahar, Mumbai
Summary: As part of the 47th annual celebrations of the Indian Drug Manufacturer’s Association, the winners of Best Patent Award, Gold and Silver Quality Excellence Awards, the G P Nair Awards and Indian Drugs Best Review Article and Research Awards will be announced and presented. IDMA’s 47th Annual Publication 2009, an update and most informative compendium will also be released on this occasion. This annual publication will present statistics, vital data and information on the pharmaceutical industry.
Prachi Rane Tel: 022-2494 4624 / 2497 4308 Fax: 022-2495 072
National symposium on ‘Chromatography—an important tool for herbal pharmaceutical industry’
Date: January 30-31, 2009
Venue: Institute of Pharmaceutical Education and Research, Borgaon, (Meghe) Wardha
Summary: The Symposium aims to enlighten the participating teachers with such related issues for the standardisation of herbal drugs. The herb industry is becoming increasingly sophisticated in the face of mounting competition and stringent regulations. It appears that an increasingly frequent part of the new herbal landscape uses several sophisticated techniques for batch to the batch standardisation for activity or potency as well as to determine the bioavailability of key compounds in herbal preparation. Industry members are making substantial investments in quality assurance methods, techniques and equipment to help ensure the production of properly identified high quality reliable herbal products.
Dr P G Yeole Convener, Institute of Pharmaceutical Education and Research Borgaon (M), Wardha- 442 001 (MS) Tel: 07152-240284 Fax: 07152-241684
Asia Pharma Expo 2009
Date: January 22-24, 2009
Venue: Dhaka, Bangladesh.
Summary: Asia Pharma Expo 2009, the fifth edition of the international exhibition on the South Asian pharmaceutical industry; is to be held at the Bangladesh China Friendship Conference Center, Dhaka, Bangladesh. More than 400 exhibiting companies representing 25 countries, including Bangladesh, India, Singapore, Gulf region, European Union, Korea, Indonesia, Taiwan, China, USA are gearing up for the final set up of their exhibit arrangements. More than 8,000 trade professionals from Bangladesh, India, Thailand, Myanmar, Nepal, Pakistan, Malaysia, Indonesia, etc. are expected to be witnessed the latest technologies and products.
The three day international pharma show has received an overwhelming response across the world. Apart from the fact that highest number of exhibiting companies from 20 countries have chosen Asia Pharma Expo 2009 as their platform of choice to exhibit their technology, the event is being supported by the Export Promotion Bureau—Bangladesh, endorsed by Bulk Drug Manufacturers Association (BDMA), Pharmaceutical Export Promotion Council (Pharmexcil), India, Engineering Export Promotion Council (EEPC), India.
It is being sponsored by two of the largest pharma giants of Bangladesh—Eskayef Bangladesh and Beximco Pharma.
Nazmul Hassan, CEO, Beximco Pharma and secretary general informed that with the highest exports of the pharma formulations, Bangladesh offers all the advantages for its strategic location in the South Asian pharma region. Bangladesh remains on top with 97 percent of the total pharma production being exported to over 72 countries. Bangladesh remains the largest producer of formulation products in LDCs, and has 18 percent share in the international business. Nazmul Hassan added that after the inclusion of the Doha declaration in TRIPS during year 2002, each and every country belonging to the LDC category now has the option not to opt for pharma product patent until year 2016, which means they can now legally reverse-engineer patented products and sell them in their domestic market as well as export to other LDCs.
Asia Pharma Expo 2009 Global, Opp. Priyadarshini Tower Near Judges, Bungalows, Bodakdev Ahmedabad 380 015 India Tel Fax: +91.79.4000.8233 / 4000.8253 / 2687.1390
Email: firstname.lastname@example.org, email@example.com
2nd Indian Peptide Symposium
Date: February 26-27, 2009
Venue: National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi
Summary: The Symposium will focus its deliberations on chemistry and structure of peptides, novel endogenous peptides, combinatorial chemistry, peptide protein interactions, structure activity relationships, molecular modeling of peptides, peptides in genomics, proteomics, peptide drug discovery and analytical techniques in peptide research. There will be speakers from all over the world who have achieved high academic excellence in peptide related research. The oral and poster presentations made by students and scientists will be selected for awards by the Indian Peptide Society. Also, there will be A Lifetime Achievement Award in the Symposium.
Rakesh Arora Secretary International Centre for Genetic Engineering and Biotechnology Aruna Asaf Ali Marg New Delhi-67 Tel: 011-26189358/60/61 Email: firstname.lastname@example.org
CPhI/ ICSE/ P-MEC India trade exhibition
Date: December 1-3, 2009
Venue: Bombay Exhibition Centre, Mumbai
Summary: The Indian market fast becoming a major global economy and with its pharmaceutical market expected to treble over the years to 2015, CPhI India 2009 is a unique chance to link up with the very best in this industry as they gather to discuss the key issues, trends and developments in one location.
C Bhaskar Senior Manager-Marketing Communications Tel: 022 66122600.
3rd Annual Conference on Drug Discovery and Clinical Development
Date: February 25-28 2009
Venue: Renaissance Hotel and Convention Center, Powai, Mumbai
Summary: This conference serves as an international and neutral forum to address current solid scientific research in India pertaining to global development of drugs and biologics. Global thought leaders and experts across the pharmaceutical, academia and regulatory agencies will convene to present drug discovery, global clinical research and scientific working groups. Keynote lectures, workshops, and parallel discussion will highlight the conference.
Leena Amanna Operations Manager DIA India Tel: 022-67653227 email@example.com Or Manoj Trivedi Marketing Consultant DIA India Mobile: 9820746323